Eastwood Bio-Medical Canada Overview
Eastwood Bio-Medical Canada (EWOOF) has a ROE of 42.45%, above the sector sector average of 11.73%.
Get informed when a big investor buys or sells
+ Follow42.45%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for EWOOF is 42.45%. That is above the sector sector average of 11.73%. Investors often review this figure alongside Eastwood Bio-Medical Canada's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, EWOOF currently prints 42.45% for ROE, while the sector average sits near 11.73%. That is roughly 261.7% above the sector mean. Large gaps often invite a closer look at Eastwood Bio-Medical Canada's growth, margins, and balance sheet.
Return on Equity shows how effectively Eastwood Bio-Medical Canada converts resources into returns. At 42.45%, EWOOF may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting EWOOF's ROE (42.45%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
